Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.
A recent report described serum anti-GQ1b ganglioside antibodies in Miller Fisher syndrome (MFS), a clinical variant of Guillain-Barré syndrome (GBS). Four consecutive cases of MFS all had high titre anti-GQ1b antibodies which were absent from all control sera including those of patients with GBS.
Willison
H J
HJ
University Department of Neurology, Southern General Hospital, Glasgow, UK.
Veitch
J
J
Paterson
G
G
Kennedy
P G
PG
D001323:Autoantibodies / Q000276:immunology*; D002855:Chromatography, Thin Layer; D003429:Cross Reactions / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D011129:Polyradiculoneuropathy / Q000276:immunology*
D001323:Autoantibodies; D005732:Gangliosides; D007074:Immunoglobulin G; D007075:Immunoglobulin M; C039129:GQ1b ganglioside